China starts precision medicine research

Published On 2016-01-10 08:35 GMT | Update On 2016-01-10 08:35 GMT

The Chinese Academy of Sciences (CAS) announced its precision medicine research plan targeting Chinese people.

Precision medicine is a medical model for high-efficiency, low-cost prevention and treatment of diseases tailored to individual patients based on their genetic content, Xinhua cited CAS as saying on Saturday.

Headed by the Beijing Institute of Genomics under the CAS, a cross-disciplinary team consisting of researchers from multiple institutes will spend four years collecting genetic information of 4,000 volunteers.

Comprehensive research will target 2,000 of all volunteers, involving whole genome sequence analysis, building genome sequence health profiles, and early warning and intervention research for the risks and drug reactions concerning the genetic factors in key chronic diseases.

The research programme also covers diabetes and cancers.

"Human genome sequence studies brought new concepts for the treatment of complicated diseases such as cancer, metabolic diseases, and cardiovascular and cerebrovascular diseases," said Zeng Changqing, the programme's chief scientist.

According to Zeng, precision medicine will realise the customisation of healthcare, and those volunteers' genome health profiles will pave way for a precision medicine initiative that covers all Chinese people.

Collection of the genetic information of the first group of volunteers is under way.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

China starts precision medicine research

Similar News

'Indians are bad': Florida patient attacks Indian-origin nurse, breaks almost every bone on her face

Frailty tied to Adverse Events in RA Patients on Biologic and Targeted Synthetic DMARDs, finds study

High dietary acid load can potentially worsen cardiometabolic risk factors, study reveals

Diabetes stigma tied to food insecurity, disordered eating and lower psychosocial well-being in diabetes patients: Study

Physical Activity may ease symptom burden of postconcussion in children, suggests study

Strength training improves knee health, lowers risk of knee osteoarthritis: Study

Sibling death in childhood tied to increased risk of early-onset cardiovascular disease: JAMA

Bisoprolol safe and effective for treating chronic obstructive pulmonary disease: Study